Modulating platelet reactivity through control of RGS18 availability.

Area of Science:

• Platelet biology
• Signal transduction
• Molecular cell biology

Background:

• Platelet activation primarily involves G-protein-coupled receptors.
• Spinophilin (SPL), SHP-1 phosphatase, and RGS18 protein form a key signaling node in platelets.
• Understanding how RGS18 binding proteins regulate platelet reactivity is crucial.

Purpose of the Study:

• To investigate if SPL and 14-3-3γ sequester RGS18, thereby regulating platelet reactivity.
• To elucidate the mechanism by which RGS18 sequestration is controlled.

Main Methods:

• Analysis of free RGS18 levels in resting and activated platelets.
• Investigating the effects of thrombin, prostaglandin I2 (PGI2), and forskolin on RGS18 levels.
• Site-directed mutagenesis of spinophilin (SPL) at Ser94 (to alanine or aspartate).
• Assessing the impact of SPL mutations on complex formation and platelet function in mouse models.

Main Results:

• Free RGS18 levels increase upon platelet activation by thrombin or inhibition of activation by PGI2/forskolin (via increased cAMP).
• Thrombin activates SHP-1, leading to SPL tyrosine dephosphorylation.
• PGI2/forskolin cause SPL Ser94 phosphorylation without altering tyrosine phosphorylation, dissociating the SPL/RGS/SHP-1 complex.
• Mutating Ser94 to alanine blocked cAMP-induced dissociation; mutating to aspartate prevented complex formation and caused loss-of-function.

Conclusions:

• Regulated sequestration and release of RGS18 by binding proteins coordinate platelet activating and inhibitory signals.
• Differential phosphorylation of SPL tyrosine and serine residues is key to controlling these signaling networks and platelet function.